development of vaccine approaches for bovine tuberculosis in free-ranging white-tailed deer

30
Development of Vaccine Approaches for Bovine Tuberculosis in Free- Ranging White-tailed Deer Mitchell Palmer, Ray Waters, Tyler Thacker National Animal Disease Center, ARS, USDA Ames, IA

Upload: fergal

Post on 23-Feb-2016

46 views

Category:

Documents


0 download

DESCRIPTION

Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer. Mitchell Palmer, Ray Waters, Tyler Thacker National Animal Disease Center, ARS, USDA Ames, IA. Wildlife Vaccines. P ublic health: rabies, plague, Lyme disease - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Mitchell Palmer, Ray Waters, Tyler ThackerNational Animal Disease Center, ARS, USDA

Ames, IA

Page 2: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Wildlife Vaccines

• Public health: rabies, plague, Lyme disease

• Livestock production: bovine TB, brucellosis, pseudorabies

• Iconic or endangered species: pasteurellosis (Bighorn sheep), anthrax (Black rhino)

Page 3: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Wildlife Vaccines-Challenges-

• Multiple species in natural transmission cycle

• Effective oral vaccine

• Safety of non-target species

• Fastidious feeding behavior

• Instability of vaccine in prevailing environmental conditions

• High reproductive rates and population turnover

• Requirement for low unit cost

– Government funding (development, purchase, delivery)

Page 4: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Agent

• Mycobacterium tuberculosis complex> 99.95% sequence homology

• M. tuberculosis• M. bovis – broadest host range• M. caprae• M. africanum• M. canetti• M. microti• M. pinnipedii• M. mungi

Page 5: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Cattle are often the original

source of M. bovis in wildlife.

As the prevalence of bovine tuberculosis

decreases in livestock, the relative

importance of wildlife reservoirs

increases.

Page 6: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Tuberculosis Eradication

• 1900- tuberculosis leading cause of death

– 10-25% of human tuberculosis due to M. bovis

• 1917- USDA eradication program

– 15,000 deaths to M. bovis

– 3x- number of foodborne deaths today

• Current surveillance is slaughter surveillance

Page 7: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Obstacles to Bovine Tuberculosis Eradication

• Importation of infected cattle– Need rapid, reliable and inexpensive test to at border crossings.

• Inability to Test and Remove Cattle– Need reliable, accurate tests to remove infected cattle without

whole herd depopulation.

• Wildlife Reservoirs– Need for vaccines for wildlife.

• Safe vaccines• Vaccine delivery systems

– Need for vaccines for cattle.• Infected vs Vaccinated

Page 8: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Tuberculosis in Wildlife• Traditional eradication methods used for livestock DO

NOT work with wildlife reservoirs.

• No country with an established wildlife reservoir of tuberculosis has successfully eradicated tuberculosis from domestic livestock.

• Vaccines viewed as possible control measure.

Page 9: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer
Page 10: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer
Page 11: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer
Page 12: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Mycobacterium bovis bacille Calmette-Guerín (BCG)

• BCG was developed 1906-1919.

• Originally isolated from a cow.

• Continuous passage led to decreased virulence

• Oldest of vaccines in use today.

• World’s most widely used vaccine (3 billion doses since 1920).

• Vaccinated individual may have positive skin test.

Albert CalmetteCamille Guerin

Page 13: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Vaccination in the US

Page 14: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Efficacy

Does vaccination prevent infection?

Does vaccination prevent disease (lesion development)?

Does vaccination decrease transmission?

Page 15: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Stage 1 Stage 2

Stage 3 Stage 4

Page 16: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer
Page 17: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Medial retropharyngeal LN

Total Score

Page 18: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Medial retropharyngeal LNBCG Danish: no lesionsBCG Pasteur and non-vaccinates: Stages I-V

LungBCG Danish: Stages I-IIIBCG Pasteur: Stages I- IIINon-vaccinates: Stages I-IV

Page 19: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Mediastinal LNStage I Stage II Stage III Stage IV Total

Oral 0 0 0 0 0

Oral Bait 0 0 0 0 0

Parenteral 4 0 11 3 18

Non-vaccinated 18 2 8 18 46

LungStage I Stage II Stage III Stage IV Total

Oral 0 0 0 0 0

Oral Bait 0 0 0 0 0

Parenteral 12 5 2 6 25

Non-vaccinated 6 8 20 15 49

Page 20: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Oral vaccination of white-tailed deer with M. bovis BCG

Vaccinates Non-vaccinates

Gross Lesions 2/17 11/16

Microscopic Lesions 4/17 11/16

M. bovis isolation 5/17 9/16

Number of tissues 8 22

Med retro LN I II III IV

Vaccinates 9 0 0 0

Non-vaccinates 26 9 5 11

Page 21: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Is it safe?

• Adverse reactions

• Non-target species

• Public health concerns– Possible exposure through venison

consumption

Page 22: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer
Page 23: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer
Page 24: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer
Page 25: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Will vaccination of deer interfere with cattle testing?

• Possible cattle exposure to BCG

• False positive skin test results

• False positive IFN-gamma test results

Page 26: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Cattle (n=12): no conversion on skin test or Bovigam, all culture results negative

Unvaccinated sentinel deer (n=10)

BCG SC vaccinated deer (n=19)

Page 27: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

13 vaccinated deer9 in-contact deer7 calves

27 weeks of indirect contact

No residual BCG

No evidence of transmission of BCG from Vaccinated deer to cattle

Immunological evidence of deer to deertransmission of BCG

Page 28: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Possums- NZBadgers- UK, Ireland

Wild boar- Spain

White-tailed deer- US

Page 29: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Testing a molasses-based bait for oral vaccination of white-tailed deer (Odocoileus virginianus) against Mycobacterium bovis- M. R. Stafne, BS, Iowa State University, College of Veterinary Medicine

Physical stability

BCG Survivability

Observations

Page 30: Development of Vaccine Approaches for Bovine Tuberculosis in Free-Ranging White-tailed Deer

Future• Bait

– Alternative Baits– Vaccine Delivery Mechanism– More field testing (attraction, stability, non-targets)

• Vaccine– Duration of immunity– Protection through secondary vaccination– Effect of high doses on protection

• Red tape– USDA, Michigan DNR, Michigan Department of Agriculture Approval

for BCG in deer– Environmental impact statement, etc.